Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jupiter Life Line HospitalsBOM:543980 -0.94%68 Return-on-Tangible-Equity is 9.76% as of Jun. 2026, which is 44% below its 10-year median of 17.30. GuruFocus rates BOM:543980 with a GF Score™ of 68/100 and a GF Value™ of ₹345.42 (Fairly Valued). The stock has 6 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Jupiter Life Line Hospitals ranks better than 55.73% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Jupiter Life Line Hospitals's annualized net income for the quarter that ended in Jun. 2026 was ₹1,499 Mil. Jupiter Life Line Hospitals's average shareholder tangible equity for the quarter that ended in Jun. 2026 was ₹15,361 Mil. Therefore, Jupiter Life Line Hospitals's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 9.76%.
The historical rank and industry rank for Jupiter Life Line Hospitals's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543980'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -0.96 Med: 17.3 Max: 23.06
Current: 13.02
During the past 6 years, Jupiter Life Line Hospitals's highest Return-on-Tangible-Equity was 23.06%. The lowest was -0.96%. And the median was 17.30%.
BOM:543980's Return-on-Tangible-Equity is ranked better than 55.73% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.605
vs BOM:543980: 13.02
Jupiter Life Line Hospitals (BOM:543980) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Jupiter Life Line Hospitals Return-on-Tangible-Equity Related Terms
Jupiter Life Line Hospitals Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jupiter Life Line Hospitals Return-on-Tangible-Equity Chart
BOM:543980 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Jupiter Life Line Hospitals's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jupiter Life Line Hospitals Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jupiter Life Line Hospitals's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Jupiter Life Line Hospitals's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.76% mean?
Jupiter Life Line Hospitals (BOM:543980) has a Return-on-Tangible-Equity of 9.76% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jupiter Life Line Hospitals and its competitors. This is 44% below median its historical median of 17.30. According to the industry distribution chart, Jupiter Life Line Hospitals ranks #255 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 44.3%.
Is Jupiter Life Line Hospitals' Return-on-Tangible-Equity too high?
Jupiter Life Line Hospitals' current Return-on-Tangible-Equity of 9.76% is 44% below median its 10-year median of 17.30. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.61. Jupiter Life Line Hospitals' value of 9.76% is 8% below this industry median. Based on the distribution chart, Jupiter Life Line Hospitals ranks #255 out of 576 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Jupiter Life Line Hospitals has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jupiter Life Line Hospitals' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jupiter Life Line Hospitals ranks #255 out of 576 companies for Return-on-Tangible-Equity. This puts Jupiter Life Line Hospitals in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.61. Jupiter Life Line Hospitals' value of 9.76% is 8% below this benchmark. While the company's 10-year median is 17.30 vs. the industry median of 10.61, Jupiter Life Line Hospitals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.61, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jupiter Life Line Hospitals's current Return-on-Tangible-Equity of 9.76% is 8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jupiter Life Line Hospitals and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jupiter Life Line Hospitals's current Return-on-Tangible-Equity is 9.76%, which is 44% below median its own 10-year median of 17.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Life Line Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals (BOM:543980) is currently considered Fairly Valued. The stock's GF Value™ is ₹345.42, compared to a current price of ₹320.10 — trading 7.3% below its estimated fair value. The current Return-on-Tangible-Equity is 9.76%, which is 44% below median its 10-year median of 17.30 and 8% below the Healthcare Providers & Services industry median of 10.61. Jupiter Life Line Hospitals' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Jupiter Life Line Hospitals (BOM:543980), the current Return-on-Tangible-Equity is 9.76% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jupiter Life Line Hospitals (BOM:543980) Overvalued in 2026?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued.
The current stock price of ₹320.10 is trading 7.3% below its estimated GF Value™ of ₹345.42.
GuruFocus considers Jupiter Life Line Hospitals to be Fairly Valued.
Key valuation signals for BOM:543980:
Return-on-Tangible-Equity: 9.76% (44% below median its 10-year median of 17.30)
GF Value™: ₹345.42 vs. price of ₹320.10 (7.3% below fair value)
Industry Position: 8% below the Healthcare Providers & Services median (#255 of 576)
No single metric tells the full story. See the BOM:543980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
68GF Score
Get the complete analysis for BOM:543980
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543980 has been successfully added to your 
